Report shows why women decline tamoxifen
28356
Boston researchers say many women at high risk for breast cancer are declining tamoxifen, the first approved drug for prevention of breast cancer.
43000
A class of hormone-blocking drugs called aromatase inhibitors was more effective in preventing breast cancer recurrence in women past menopause than was tamoxifen, a medication now prescribed
690775
NEW YORK  - Invasive breast cancer rates have fallen since the substantial decline in postmenopausal hormone replacement therapy (HRT) occurred, even after a decline in breast cancer screening rates, according to findings published in the 5th Journal of the National Cancer Institute.
262971
SAN ANTONIO -- This week's news that a big drop in cases of breast cancer could be due to millions of women going off menopause hormones may lead even more of them to abandon the pills.
887
A new type of breast cancer drug is superior to the old standard, tamoxifen, in older women and should now be the first drug used to treat
197102
Older women suffering from breast cancer should take a newer drug in place of the tried-and-true tamoxifen, researchers from the US and Britain have announced.
279261
Women from more deprived backgrounds have a lower breast cancer survival rate, research suggests.
507184
Women with breast cancer who take tamoxifen are less likely to have a heart attack than women with other types of cancer who are not taking the drug, according to a new report.
596124
In a startling turnaround, breast cancer rates in the United States dropped dramatically in 2003, and experts said they believe it is because many women stopped taking hormone pills.
56071
Women who switch from the breast cancer pill tamoxifen to a newer class of drugs called aromatase inhibitors live longer, Italian researchers reported on Monday.
268717
Hormone replacement therapy, breast surgery and a low body weight all make it harder to detect breast cancer, scientists have discovered.
535606
About a quarter of U.S. women who  stopped taking hormone replacement therapy after it was found  to raise the risk of heart disease and some cancers have gone  back on it, the American College of Obstetricians and  Gynecologists said on Friday.
757275
About a quarter of U.S. women who stopped taking hormone replacement therapy after it was found to raise the risk of heart disease and some cancers have gone back on it, the American College of Obstetricians and Gynecologists said on Friday.
107122
A drop in breast cancer cases may due to women eschewing Hormone Replacement Therapy, a study suggests.
629612
Women with a high risk of breast  cancer are declining to take tamoxifen because they are afraid  of side effects, even though the drug can protect them from the  cancer, researchers reported on Tuesday.
754325
NEW YORK  - After approximately 8 years, postmenopausal women with hormone-sensitive breast cancer who received (Arimidex), generically known as anastrazole, had a lower risk of recurrence than women taking tamoxifen, investigators reported at the annual meeting of the San Antonio Breast Cancer Symposium.
461307
A dramatic decline in breast-cancer rates may be linked to a decrease in the number of women using hormone therapy. What women need to know about the new findings.